Loading…
Medical Nutrition Equity Act of 2019
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
1d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Medical Nutrition Equity Act of 2019 This bill expands coverage under Medicare, Medicaid, other specified federal health-care programs, and private health insurance to include foods, vitamins, and individual amino acids that are medically necessary for the management of certain digestive and metabolic disorders and conditions.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (9)
Referred to the Subcommittee on Military Personnel.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2020 · fourth_quarter · Health Issues
Support the Medical Nutrition Equity Act which requires all payers (Medicare, Medicaid, FEHBP and commercial insurance plans) to cover medically necessary nutrition for patients with diseases and disorders of the gastrointestinal system and metabolic disorders. H.R.2501/S. 3567 Discussion with the Administration about disruptions in access to ethanol locks for placement in central venous catheters to prevent or treat central line-associated blood stream infections (CLABSI).
Client expense: Not reported · Firm income: $21,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Health Issues
Educate policymakers about medical foods and the benefits of H.R. 2501 / S. 3657, the Medical Nutrition Equity Act of 2020.
Client expense: Not reported · Firm income: $60,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medical/Disease Research/Clinical Labs
Drug pricing, gene therapy, and rare disease funding generally; H.R. 4393 - Advancing Access to Precision Medicine; H.R. 2507/S. 2158 Newborn Screening Saves Lives Reauthorization Act; H.R. 8045 - Genome Editing Threat Assessment Act; HR 2501 - Medical Nutrition Equity Act;
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Promote federal funding for mitochondrial disease research, FY21 Defense Appropriations Act (Title V - Health); FY21 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Budget/Appropriations
Promote federal funding for mitochondrial disease research, FY21 Defense Appropriations Act (Title V - Health); FY21 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
General medical nutrition issues, medical nutrition equity act (HR. 2501), medical foods, dietary guidelines for americans, competitive bidding
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
General medical nutrition issue, medical foods regulatory category, medical nutrition equity act (HR. 2501), dietary guidelines for americans.
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Defense
S. 2154 S. 2115 S. 2109 S. 2060 S. 2058 S. 2052 S. 1991 S. 1860 S. 1800 S. 1799 S. 1798 S. 1790 S. 1789 S. 1771 S. 1761 S. 1690 S. 1680 S. 1679 S. 1615 S. 1580 S. 1555 S. 1542 S. 1534 S. 1526 S. 1513 S. 1512 S. 1511 S. 1503 S. 1501 S. 1500 S. 1498 S. 1495 S. 1493 S. 1471 S. 1467 S. 1413 S. 1383 S. 1360 S. 1348 S. 1320 S. 1316 S. 1271 S. 1237 S. 1229 S. 1218 S. 1215 S. 1156 S. 1143 S. 1136 S. 1096 S. 1049 S. 986 S. 974 S. 965 S. 871 S. 858 S. 703 S. 675 S. 645 S. 622 S. 401 S. 373 S. 208 S. 191 S. 164 S. 114 S. 98 S. 30 S.J.Res. 10 S.Res. 160 S.Res. 72 S.Res. 24 S.Res. 11 S.Res. 42 H.R. 1553 H.R. 2565 H.R. 489 H.Res. 403 H.R. 3746 H.R. 2970 H.R. 2942 H.R. 2941 H.R. 2195 H.R. 2056 H.R. 1779 H.R. 1092 H.R. 955 H.R. 2326 H.J.Res. 46 H.R. 1293 H.R. 3611 H.R. 3038 H.R. 2495 H.R. 3306 H.R. 2795 H.R. 3458 H.R. 2945 H.R. 1891 H.R. 3161 H.Con.Res. 18 S.Con.Res. 3 H.R. 2406 H.R. 3802 H.R. 2342 H.R. 1090 H.R. 814 H.R. 2022 H.R. 2689 H.R. 1076 H.R. 1931 H.R. 112 H.R. 3420 H.R. 2098 H.R. 1078 H.R. 1893 H.R. 2483 H.R. 2226 H.R. 3524 H.R. 3508 H.R. 336 H.R. 1837 H.R. 3576 H.R. 3064 H.R. 2949 H.R. 2419 H.R. 2354 H.R. 1653 H.R. 910 H.Res. 442 H.Res. 309 H.Res. 302 H.Res. 214 H.R. 2166 H.R. 618 H.R. 2979 H.R. 3190 H.R. 1193 H.R. 1810 H.R. 2904 H.R. 442 H.R. 1332 H.R. 3652 H.R. 3840 H.R. 3801 H.R. 3727 H.R. 3724 H.R. 3658 H.R. 3588 H.R. 3567 H.R. 3505 H.R. 3467 H.R. 3400 H.R. 3313 H.R. 3309 H.R. 3266 H.R. 3247 H.R. 3227 H.R. 3226 H.R. 3216 H.R. 3191 H.R. 3186 H.R. 3185 H.R. 3181 H.R. 3177 H.R. 3176 H.R. 3175 H.R. 3174 H.R. 3173 H.R. 3166 H.R. 3148 H.R. 3143 H.R. 3137 H.R. 3132 H.R. 3093 H.R. 3087 H.R. 3084 H.R. 3065 H.R. 3046 H.R. 3045 H.R. 3041 H.R. 3034 H.R. 3015 H.R. 2954 H.R. 2953 H.R. 2952 H.R. 2944 H.R. 2937 H.R. 2907 H.R. 2892 H.R. 2880 H.R. 2869 H.R. 2814 H.R. 2811 H.R. 2794 H.R. 2767 H.R. 2762 H.R. 2759 H.R. 2756 H.R. 2598 H.R. 2555 H.R. 2554 H.R. 2450 H.R. 2432 H.R. 2395 H.R. 2330 H.R. 2255 H.R. 2254 H.R. 2253 H.R. 2252 H.R. 2249 H.R. 2171 H.R. 2091 H.R. 2033 H.R. 1863 H.R. 1801 H.R. 1792 H.R. 1746 H.R. 1714 H.R. 1638 H.R. 1462 H.R. 1403 H.R. 1258 H.R. 1086 H.R. 1032 H.R. 1019 H.R. 1017 H.R. 914 H.R. 859 H.R. 853 H.R. 700 H.R. 620 H.R. 613 H.R. 563 H.R. 553 H.R. 491 H.R. 463 H.R. 351 H.R. 344 H.R. 311 H.R. 248 H.R. 238 H.Con.Res. 49 H.Con.Res. 43 H.Res. 468 H.Res. 440 H.Res. 361 H.Res. 229 H.Res. 219 H.Res. 177 H.Res. 134 H.Res. 126 H.Res. 124 H.Res. 99 H.Res. 96 H.Res. 29 S. 252 H.R. 2500 H.R. 2257 H.R. 1567 H.R. 2016 H.R. 3626 H.R. 3233 H.R. 2727 H.R. 2707 H.R. 2280 H.R. 2060 H.R. 1795 H.R. 1249 H.R. 1231 H.R. 1004 H.R. 889 H.R. 2987 H.R. 2028 H.Res. 413 H.R. 2388 H.R. 3014 H.R. 3517 H.R. 3178 H.R. 3072 H.R. 2947 H.R. 2886 H.R. 2618 H.R. 2617 H.R. 1911 H.R. 663 H.R. 333 H.R. 303 H.Res. 455 H.Res. 269 H.Res. 39 H.R. 2384 H.R. 2401 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 3042 H.R. 1201 H.R. 1966 H.R. 1183 H.R. 3219 H.R. 2699 H.Res. 288 H.R. 2803 H.R. 3815 H.R. 3429 H.R. 3416 H.R. 2371 H.R. 2501 H.R. 3523 H.R. 1384
2020 · third_quarter · Health Issues
Support the Medical Nutrition Equity Act which requires all payers (Medicare, Medicaid, FEHBP and commercial insurance plans) to cover medically necessary nutrition for patients with diseases and disorders of the gastrointestinal system and metabolic disorders. H.R.2501/S. 3567
Client expense: Not reported · Firm income: $21,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
Educate policymakers about medical foods and the benefits of H.R. 2501 / S. 3657, the Medical Nutrition Equity Act of 2020.
Client expense: Not reported · Firm income: $60,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Medical/Disease Research/Clinical Labs
Drug pricing and gene therapy, generally; H.R. 4393 - Advancing Access to Precision Medicine; H.R. 2507/S. 2158 Newborn Screening Saves Lives Reauthorization Act; H.R. 8045 - Genome Editing Threat Assessment Act; HR 2501 - Medical Nutrition Equity Act;
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Budget/Appropriations
Promote federal funding for mitochondrial disease research, FY21 Defense Appropriations Act (Title V - Health); FY21 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
Promote federal funding for mitochondrial disease research, FY21 Defense Appropriations Act (Title V - Health); FY21 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
General medical nutrition issues, medical nutrition equity act (HR. 2501), medical foods, dietary guidelines for americans, competitive bidding
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Food Industry (safety, labeling, etc.)
General medical nutrition issue, medical foods regulatory category, medical nutrition equity act (HR. 2501), dietary guidelines for americans.
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
Support the Medical Nutrition Equity Act which requires all payers (Medicare, Medicaid, FEHBP and commercial insurance plans) to cover medically necessary nutrition for patients with diseases and disorders of the gastrointestinal system and metabolic disorders. H.R.2501/S. 3567 Medical Nutrition Equity Act of 2019 Support the Investment in Tomorrow's Pediatric Health Care Workforce Act (S. 2443) and the Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER)forHealthAct (H.R. 2781) to reauthorize the Pediatric Subspecialty Loan Repayment Program.
Client expense: Not reported · Firm income: $21,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
Promote federal funding for mitochondrial disease research, FY21 Defense Appropriations Act (Title V - Health); FY21 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Budget/Appropriations
Promote federal funding for mitochondrial disease research, FY21 Defense Appropriations Act (Title V - Health); FY21 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Food Industry (safety, labeling, etc.)
General medical nutrition issue, medical foods regulatory category, medical nutrition equity act (HR. 2501), dietary guidelines for americans.
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
General medical nutrition issues, medical nutrition equity act (HR. 2501), medical foods, dietary guidelines for americans, competitive bidding
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Defense
S. 2154 S. 2115 S. 2109 S. 2060 S. 2058 S. 2052 S. 1991 S. 1860 S. 1800 S. 1799 S. 1798 S. 1790 S. 1789 S. 1771 S. 1761 S. 1690 S. 1680 S. 1679 S. 1615 S. 1580 S. 1555 S. 1542 S. 1534 S. 1526 S. 1513 S. 1512 S. 1511 S. 1503 S. 1501 S. 1500 S. 1498 S. 1495 S. 1493 S. 1471 S. 1467 S. 1413 S. 1383 S. 1360 S. 1348 S. 1320 S. 1316 S. 1271 S. 1237 S. 1229 S. 1218 S. 1215 S. 1156 S. 1143 S. 1136 S. 1096 S. 1049 S. 986 S. 974 S. 965 S. 871 S. 858 S. 703 S. 675 S. 645 S. 622 S. 401 S. 373 S. 208 S. 191 S. 164 S. 114 S. 98 S. 30 S.J.Res. 10 S.Res. 160 S.Res. 72 S.Res. 24 S.Res. 11 S.Res. 42 H.R. 1553 H.R. 2565 H.R. 489 H.Res. 403 H.R. 3746 H.R. 2970 H.R. 2942 H.R. 2941 H.R. 2195 H.R. 2056 H.R. 1779 H.R. 1092 H.R. 955 H.R. 2326 H.J.Res. 46 H.R. 1293 H.R. 3611 H.R. 3038 H.R. 2495 H.R. 3306 H.R. 2795 H.R. 3458 H.R. 2945 H.R. 1891 H.R. 3161 H.Con.Res. 18 S.Con.Res. 3 H.R. 2406 H.R. 3802 H.R. 2342 H.R. 1090 H.R. 814 H.R. 2022 H.R. 2689 H.R. 1076 H.R. 1931 H.R. 112 H.R. 3420 H.R. 2098 H.R. 1078 H.R. 1893 H.R. 2483 H.R. 2226 H.R. 3524 H.R. 3508 H.R. 336 H.R. 1837 H.R. 3576 H.R. 3064 H.R. 2949 H.R. 2419 H.R. 2354 H.R. 1653 H.R. 910 H.Res. 442 H.Res. 309 H.Res. 302 H.Res. 214 H.R. 2166 H.R. 618 H.R. 2979 H.R. 3190 H.R. 1193 H.R. 1810 H.R. 2904 H.R. 442 H.R. 1332 H.R. 3652 H.R. 3840 H.R. 3801 H.R. 3727 H.R. 3724 H.R. 3658 H.R. 3588 H.R. 3567 H.R. 3505 H.R. 3467 H.R. 3400 H.R. 3313 H.R. 3309 H.R. 3266 H.R. 3247 H.R. 3227 H.R. 3226 H.R. 3216 H.R. 3191 H.R. 3186 H.R. 3185 H.R. 3181 H.R. 3177 H.R. 3176 H.R. 3175 H.R. 3174 H.R. 3173 H.R. 3166 H.R. 3148 H.R. 3143 H.R. 3137 H.R. 3132 H.R. 3093 H.R. 3087 H.R. 3084 H.R. 3065 H.R. 3046 H.R. 3045 H.R. 3041 H.R. 3034 H.R. 3015 H.R. 2954 H.R. 2953 H.R. 2952 H.R. 2944 H.R. 2937 H.R. 2907 H.R. 2892 H.R. 2880 H.R. 2869 H.R. 2814 H.R. 2811 H.R. 2794 H.R. 2767 H.R. 2762 H.R. 2759 H.R. 2756 H.R. 2598 H.R. 2555 H.R. 2554 H.R. 2450 H.R. 2432 H.R. 2395 H.R. 2330 H.R. 2255 H.R. 2254 H.R. 2253 H.R. 2252 H.R. 2249 H.R. 2171 H.R. 2091 H.R. 2033 H.R. 1863 H.R. 1801 H.R. 1792 H.R. 1746 H.R. 1714 H.R. 1638 H.R. 1462 H.R. 1403 H.R. 1258 H.R. 1086 H.R. 1032 H.R. 1019 H.R. 1017 H.R. 914 H.R. 859 H.R. 853 H.R. 700 H.R. 620 H.R. 613 H.R. 563 H.R. 553 H.R. 491 H.R. 463 H.R. 351 H.R. 344 H.R. 311 H.R. 248 H.R. 238 H.Con.Res. 49 H.Con.Res. 43 H.Res. 468 H.Res. 440 H.Res. 361 H.Res. 229 H.Res. 219 H.Res. 177 H.Res. 134 H.Res. 126 H.Res. 124 H.Res. 99 H.Res. 96 H.Res. 29 S. 252 H.R. 2500 H.R. 2257 H.R. 1567 H.R. 2016 H.R. 3626 H.R. 3233 H.R. 2727 H.R. 2707 H.R. 2280 H.R. 2060 H.R. 1795 H.R. 1249 H.R. 1231 H.R. 1004 H.R. 889 H.R. 2987 H.R. 2028 H.Res. 413 H.R. 2388 H.R. 3014 H.R. 3517 H.R. 3178 H.R. 3072 H.R. 2947 H.R. 2886 H.R. 2618 H.R. 2617 H.R. 1911 H.R. 663 H.R. 333 H.R. 303 H.Res. 455 H.Res. 269 H.Res. 39 H.R. 2384 H.R. 2401 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 3042 H.R. 1201 H.R. 1966 H.R. 1183 H.R. 3219 H.R. 2699 H.Res. 288 H.R. 2803 H.R. 3815 H.R. 3429 H.R. 3416 H.R. 2371 H.R. 2501 H.R. 3523 H.R. 1384
2020 · first_quarter · Health Issues
Support the Medical Nutrition Equity Act which requires all payers (Medicare, Medicaid, FEHBP and commercial insurance plans) to cover medically necessary nutrition for patients with diseases and disorders of the gastrointestinal system and metabolic disorders. H.R.2501, Medical Nutrition Equity Act of 2019 Support the Investment in Tomorrow's Pediatric Health Care Workforce Act (S. 2443) and the Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER)forHealthAct (H.R. 2781) to reauthorize the Pediatric Subspecialty Loan Repayment Program. Endorse Senate resolution (S.Res.546) recognizing the week of March 15-21, 2020, as "National Poison Prevention Week" and encouraging communities across the United States to raise awareness of the dangers of poisoning and promote poisoning prevention. I
Client expense: Not reported · Firm income: $21,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for passage of H.R. 4393, the Advancing Access to Precision Medicine Act, provide for a State option under the State Medicaid plan to provide DNA sequencing clinical services for certain children. Advocated for funding for the FDA Orphan Products Grants Program. Advocated for passage of the Medical Nutrition Equity Act (H.R.2501). Advocated for Members to join the Rare Disease Caucus and the ALS Caucus. Advocated for passage of H.R. 3235, the Access to Genetic Counselor Services Act of 2019, to provide for expanded coverage of services provided by genetic counselors. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 2507 / S. 2158, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for increased funding for National Institutes of Health, Food and Drug Administration, Health Resources and Services Administration, and other health agencies that conduct research on neuromuscular disease and provide services to those with these conditions. Advocated for adequate, affordable, accessible health coverage for individuals with neuromuscular conditions. Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019. Advocated for maintaining strong incentives for rare disease drug development included within the Orphan Drug Act (PL 97-414) Advocated for the continuance of the Rare Pediatric Disease Priority Review Voucher Program within the context of the Creating Hope Reauthorization Act (H.R.4439) Advocated for passage of Families First Coronavirus Response Act (HR 6201) and Coronavirus Preparedness and Response Supplemental Appropriations Act (HR 6704). Advocated for a joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers" (H.J. Res. 74 / S.J. Res. 52).
2020 · first_quarter · Health Issues
Promote federal funding for mitochondrial disease research, FY21 Defense Appropriations Act (Title V - Health); FY21 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Budget/Appropriations
Promote federal funding for mitochondrial disease research, FY21 Defense Appropriations Act (Title V - Health); FY21 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Health Issues
General medical nutrition issues, medical nutrition equity act (HR. 2501), medical foods, dietary guidelines for americans, competitive bidding
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Food Industry (safety, labeling, etc.)
General medical nutrition issue, medical foods regulatory category, medical nutrition equity act (HR. 2501), dietary guidelines for americans.
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Defense
S. 2154 S. 2115 S. 2109 S. 2060 S. 2058 S. 2052 S. 1991 S. 1860 S. 1800 S. 1799 S. 1798 S. 1790 S. 1789 S. 1771 S. 1761 S. 1690 S. 1680 S. 1679 S. 1615 S. 1580 S. 1555 S. 1542 S. 1534 S. 1526 S. 1513 S. 1512 S. 1511 S. 1503 S. 1501 S. 1500 S. 1498 S. 1495 S. 1493 S. 1471 S. 1467 S. 1413 S. 1383 S. 1360 S. 1348 S. 1320 S. 1316 S. 1271 S. 1237 S. 1229 S. 1218 S. 1215 S. 1156 S. 1143 S. 1136 S. 1096 S. 1049 S. 986 S. 974 S. 965 S. 871 S. 858 S. 703 S. 675 S. 645 S. 622 S. 401 S. 373 S. 208 S. 191 S. 164 S. 114 S. 98 S. 30 S.J.Res. 10 S.Res. 160 S.Res. 72 S.Res. 24 S.Res. 11 S.Res. 42 H.R. 1553 H.R. 2565 H.R. 489 H.Res. 403 H.R. 3746 H.R. 2970 H.R. 2942 H.R. 2941 H.R. 2195 H.R. 2056 H.R. 1779 H.R. 1092 H.R. 955 H.R. 2326 H.J.Res. 46 H.R. 1293 H.R. 3611 H.R. 3038 H.R. 2495 H.R. 3306 H.R. 2795 H.R. 3458 H.R. 2945 H.R. 1891 H.R. 3161 H.Con.Res. 18 S.Con.Res. 3 H.R. 2406 H.R. 3802 H.R. 2342 H.R. 1090 H.R. 814 H.R. 2022 H.R. 2689 H.R. 1076 H.R. 1931 H.R. 112 H.R. 3420 H.R. 2098 H.R. 1078 H.R. 1893 H.R. 2483 H.R. 2226 H.R. 3524 H.R. 3508 H.R. 336 H.R. 1837 H.R. 3576 H.R. 3064 H.R. 2949 H.R. 2419 H.R. 2354 H.R. 1653 H.R. 910 H.Res. 442 H.Res. 309 H.Res. 302 H.Res. 214 H.R. 2166 H.R. 618 H.R. 2979 H.R. 3190 H.R. 1193 H.R. 1810 H.R. 2904 H.R. 442 H.R. 1332 H.R. 3652 H.R. 3840 H.R. 3801 H.R. 3727 H.R. 3724 H.R. 3658 H.R. 3588 H.R. 3567 H.R. 3505 H.R. 3467 H.R. 3400 H.R. 3313 H.R. 3309 H.R. 3266 H.R. 3247 H.R. 3227 H.R. 3226 H.R. 3216 H.R. 3191 H.R. 3186 H.R. 3185 H.R. 3181 H.R. 3177 H.R. 3176 H.R. 3175 H.R. 3174 H.R. 3173 H.R. 3166 H.R. 3148 H.R. 3143 H.R. 3137 H.R. 3132 H.R. 3093 H.R. 3087 H.R. 3084 H.R. 3065 H.R. 3046 H.R. 3045 H.R. 3041 H.R. 3034 H.R. 3015 H.R. 2954 H.R. 2953 H.R. 2952 H.R. 2944 H.R. 2937 H.R. 2907 H.R. 2892 H.R. 2880 H.R. 2869 H.R. 2814 H.R. 2811 H.R. 2794 H.R. 2767 H.R. 2762 H.R. 2759 H.R. 2756 H.R. 2598 H.R. 2555 H.R. 2554 H.R. 2450 H.R. 2432 H.R. 2395 H.R. 2330 H.R. 2255 H.R. 2254 H.R. 2253 H.R. 2252 H.R. 2249 H.R. 2171 H.R. 2091 H.R. 2033 H.R. 1863 H.R. 1801 H.R. 1792 H.R. 1746 H.R. 1714 H.R. 1638 H.R. 1462 H.R. 1403 H.R. 1258 H.R. 1086 H.R. 1032 H.R. 1019 H.R. 1017 H.R. 914 H.R. 859 H.R. 853 H.R. 700 H.R. 620 H.R. 613 H.R. 563 H.R. 553 H.R. 491 H.R. 463 H.R. 351 H.R. 344 H.R. 311 H.R. 248 H.R. 238 H.Con.Res. 49 H.Con.Res. 43 H.Res. 468 H.Res. 440 H.Res. 361 H.Res. 229 H.Res. 219 H.Res. 177 H.Res. 134 H.Res. 126 H.Res. 124 H.Res. 99 H.Res. 96 H.Res. 29 S. 252 H.R. 2500 H.R. 2257 H.R. 1567 H.R. 2016 H.R. 3626 H.R. 3233 H.R. 2727 H.R. 2707 H.R. 2280 H.R. 2060 H.R. 1795 H.R. 1249 H.R. 1231 H.R. 1004 H.R. 889 H.R. 2987 H.R. 2028 H.Res. 413 H.R. 2388 H.R. 3014 H.R. 3517 H.R. 3178 H.R. 3072 H.R. 2947 H.R. 2886 H.R. 2618 H.R. 2617 H.R. 1911 H.R. 663 H.R. 333 H.R. 303 H.Res. 455 H.Res. 269 H.Res. 39 H.R. 2384 H.R. 2401 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 3042 H.R. 1201 H.R. 1966 H.R. 1183 H.R. 3219 H.R. 2699 H.Res. 288 H.R. 2803 H.R. 3815 H.R. 3429 H.R. 3416 H.R. 2371 H.R. 2501 H.R. 3523 H.R. 1384
2019 · fourth_quarter · Health Issues
Support the Medical Nutrition Equity Act which requires all payers (Medicare, Medicaid, FEHBP and commercial insurance plans) to cover medically necessary nutrition for patients with diseases and disorders of the gastrointestinal system and metabolic disorders. H.R.2501, Medical Nutrition Equity Act of 2019 Support the Investment in Tomorrow's Pediatric Health Care Workforce Act (S. 2443) and the Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER)forHealthAct (H.R. 2781) to reauthorize the Pediatric Subspecialty Loan Repayment Program.
Client expense: Not reported · Firm income: $21,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Food Industry (safety, labeling, etc.)
General medical nutrition issue, medical foods regulatory category, medical nutrition equity act (HR. 2501), dietary guidelines for americans.
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
General medical nutrition issues, medical nutrition equity act (HR. 2501), medical foods, dietary guidelines for americans, competitive bidding
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Health issues impacting patients with rare diseases. H.R.4228: Rare disease Advancement, Surveillance Research, and Education (RARE) Act of 2019. Rare Cancer. Step Therapy. H.R.2279/S.2546: Safe Step Act. Newborn Screening. H.R.2507/S.2158: Newborn Screening Saves Lives Reauthorization Act of 2019. H.R.1379/S.560: Ensuring Lasting Smiles Act. Pediatric Research Equity Act (PREA). Biosimilars. Genetic Testing. Clinical Trials. Institutional Review Boards. Medical Devices. Medical Foods. H.R.2501: Medical Nutrition Equity Act of 2019. Public Law No: 111-148: The Patient Protection and Affordable Care Act. S.1895: Lower Health Care Costs Act. Surprise Medical Billing. Dr. Hahn's Confirmation.
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2019 · fourth_quarter · Budget/Appropriations
Promote federal funding for mitochondrial disease research, FY20 Defense Appropriations Act (Title V - Health); FY20 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Promote federal funding for mitochondrial disease research, FY20 Defense Appropriations Act (Title V - Health); FY20 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2019 · third_quarter · Food Industry (safety, labeling, etc.)
General medical nutrition issue, medical foods regulatory category, medical nutrition equity act (HR. 2501), dietary guidelines for americans.
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
General medical nutrition issues, medical nutrition equity act (HR. 2501), medical foods, dietary guidelines for americans, competitive bidding
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Support the Medical Nutrition Equity Act which requires all payers (Medicare, Medicaid, FEHBP and commercial insurance plans) to cover medically necessary nutrition for patients with diseases and disorders of the gastrointestinal system and metabolic disorders. H.R.2501, Medical Nutrition Equity Act of 2019 Support the Investment in Tomorrow's Pediatric Health Care Workforce Act (S. 2443) and the Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER)forHealthAct (H.R. 2781) to reauthorize the Pediatric Subspecialty Loan Repayment Program.
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Defense
S. 2154 S. 2115 S. 2109 S. 2060 S. 2058 S. 2052 S. 1991 S. 1860 S. 1800 S. 1799 S. 1798 S. 1790 S. 1789 S. 1771 S. 1761 S. 1690 S. 1680 S. 1679 S. 1615 S. 1580 S. 1555 S. 1542 S. 1534 S. 1526 S. 1513 S. 1512 S. 1511 S. 1503 S. 1501 S. 1500 S. 1498 S. 1495 S. 1493 S. 1471 S. 1467 S. 1413 S. 1383 S. 1360 S. 1348 S. 1320 S. 1316 S. 1271 S. 1237 S. 1229 S. 1218 S. 1215 S. 1156 S. 1143 S. 1136 S. 1096 S. 1049 S. 986 S. 974 S. 965 S. 871 S. 858 S. 703 S. 675 S. 645 S. 622 S. 401 S. 373 S. 208 S. 191 S. 164 S. 114 S. 98 S. 30 S.J.Res. 10 S.Res. 160 S.Res. 72 S.Res. 24 S.Res. 11 S.Res. 42 H.R. 1553 H.R. 2565 H.R. 489 H.Res. 403 H.R. 3746 H.R. 2970 H.R. 2942 H.R. 2941 H.R. 2195 H.R. 2056 H.R. 1779 H.R. 1092 H.R. 955 H.R. 2326 H.J.Res. 46 H.R. 1293 H.R. 3611 H.R. 3038 H.R. 2495 H.R. 3306 H.R. 2795 H.R. 3458 H.R. 2945 H.R. 1891 H.R. 3161 H.Con.Res. 18 S.Con.Res. 3 H.R. 2406 H.R. 3802 H.R. 2342 H.R. 1090 H.R. 814 H.R. 2022 H.R. 2689 H.R. 1076 H.R. 1931 H.R. 112 H.R. 3420 H.R. 2098 H.R. 1078 H.R. 1893 H.R. 2483 H.R. 2226 H.R. 3524 H.R. 3508 H.R. 336 H.R. 1837 H.R. 3576 H.R. 3064 H.R. 2949 H.R. 2419 H.R. 2354 H.R. 1653 H.R. 910 H.Res. 442 H.Res. 309 H.Res. 302 H.Res. 214 H.R. 2166 H.R. 618 H.R. 2979 H.R. 3190 H.R. 1193 H.R. 1810 H.R. 2904 H.R. 442 H.R. 1332 H.R. 3652 H.R. 3840 H.R. 3801 H.R. 3727 H.R. 3724 H.R. 3658 H.R. 3588 H.R. 3567 H.R. 3505 H.R. 3467 H.R. 3400 H.R. 3313 H.R. 3309 H.R. 3266 H.R. 3247 H.R. 3227 H.R. 3226 H.R. 3216 H.R. 3191 H.R. 3186 H.R. 3185 H.R. 3181 H.R. 3177 H.R. 3176 H.R. 3175 H.R. 3174 H.R. 3173 H.R. 3166 H.R. 3148 H.R. 3143 H.R. 3137 H.R. 3132 H.R. 3093 H.R. 3087 H.R. 3084 H.R. 3065 H.R. 3046 H.R. 3045 H.R. 3041 H.R. 3034 H.R. 3015 H.R. 2954 H.R. 2953 H.R. 2952 H.R. 2944 H.R. 2937 H.R. 2907 H.R. 2892 H.R. 2880 H.R. 2869 H.R. 2814 H.R. 2811 H.R. 2794 H.R. 2767 H.R. 2762 H.R. 2759 H.R. 2756 H.R. 2598 H.R. 2555 H.R. 2554 H.R. 2450 H.R. 2432 H.R. 2395 H.R. 2330 H.R. 2255 H.R. 2254 H.R. 2253 H.R. 2252 H.R. 2249 H.R. 2171 H.R. 2091 H.R. 2033 H.R. 1863 H.R. 1801 H.R. 1792 H.R. 1746 H.R. 1714 H.R. 1638 H.R. 1462 H.R. 1403 H.R. 1258 H.R. 1086 H.R. 1032 H.R. 1019 H.R. 1017 H.R. 914 H.R. 859 H.R. 853 H.R. 700 H.R. 620 H.R. 613 H.R. 563 H.R. 553 H.R. 491 H.R. 463 H.R. 351 H.R. 344 H.R. 311 H.R. 248 H.R. 238 H.Con.Res. 49 H.Con.Res. 43 H.Res. 468 H.Res. 440 H.Res. 361 H.Res. 229 H.Res. 219 H.Res. 177 H.Res. 134 H.Res. 126 H.Res. 124 H.Res. 99 H.Res. 96 H.Res. 29 S. 252 H.R. 2500 H.R. 2257 H.R. 1567 H.R. 2016 H.R. 3626 H.R. 3233 H.R. 2727 H.R. 2707 H.R. 2280 H.R. 2060 H.R. 1795 H.R. 1249 H.R. 1231 H.R. 1004 H.R. 889 H.R. 2987 H.R. 2028 H.Res. 413 H.R. 2388 H.R. 3014 H.R. 3517 H.R. 3178 H.R. 3072 H.R. 2947 H.R. 2886 H.R. 2618 H.R. 2617 H.R. 1911 H.R. 663 H.R. 333 H.R. 303 H.Res. 455 H.Res. 269 H.Res. 39 H.R. 2384 H.R. 2401 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 3042 H.R. 1201 H.R. 1966 H.R. 1183 H.R. 3219 H.R. 2699 H.Res. 288 H.R. 2803 H.R. 3815 H.R. 3429 H.R. 3416 H.R. 2371 H.R. 2501 H.R. 3523 H.R. 1384
2019 · third_quarter · Health Issues
Health issues impacting patients with rare diseases. H.R.2279/S.2546: Safe Step Act. H.R.4228: Rare disease Advancement, surveillance Research, and Education (RARE) Act of 2019. H.Res.242: Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases. Docket No. FDA-2019-D-1264: Enhancing the Diversity of Clinical Trial Populations-Eligibility Criteria, Enrollment Practices, and Trial Designs; Draft Guidance for Industry; Availability. Newborn Screening. H.R.2507/S.2158: Newborn Screening Saves Lives Reauthorization Act of 2019. H.R.1379/S.560: Ensuring Lasting Smiles Act. H.R.4439: Creating Hope Reauthorization Act. Biosimilars. Genetic Testing. FDA User Fee Reauthorization (Legislation Not Yet Introduced). Medical Foods. H.R.2501: Medical Nutrition Equity Act of 2019. Section 1557 of the Patient Protection and Affordable Care Act. RIN 0938-ZB45: Patient Protection and Affordable Care Act; Increasing Consumer Choice Through the Sale of Individual Health Insurance. Enrollment Practices. Copay Accumulator Adjustment Programs (CAAPs). CMS-2406-P/RIN 0938-AT41/: Methods for Assuring Access to Care; Exceptions for High Managed Care Penetration and Rate Reduction Threshold. Docket No. HHS-OCR-2019-0007: Nondiscrimination in Health and Health Education Programs or Activities. Docket No. FDA-2019-N-1619: List of Patient Preference-Sensitive Priorities; Establishment of a Public Docket; Request for Comments.
Client expense: $60,000 · Firm income: Not reported
2019 · third_quarter · Budget/Appropriations
Promote federal funding for mitochondrial disease research, FY20 Defense Appropriations Act (Title V - Health); FY20 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Promote federal funding for mitochondrial disease research, FY20 Defense Appropriations Act (Title V - Health); FY20 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2019 · second_quarter · Health Issues
Support the Medical Nutrition Equity Act which requires all payers (Medicare, Medicaid, FEHBP and commercial insurance plans) to cover medically necessary nutrition for patients with diseases and disorders of the gastrointestinal system and metabolic disorders. H.R.2501, Medical Nutrition Equity Act of 2019
Client expense: Not reported · Firm income: $21,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Health Issues
General medical nutrition issues, medical nutrition equity act (HR. 2501), medical foods, dietary guidelines for americans, competitive bidding
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Food Industry (safety, labeling, etc.)
General medical nutrition issue, medical foods regulatory category, medical nutrition equity act (HR. 2501), dietary guidelines for americans.
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Defense
S. 2154 S. 2115 S. 2109 S. 2060 S. 2058 S. 2052 S. 1991 S. 1860 S. 1800 S. 1799 S. 1798 S. 1790 S. 1789 S. 1771 S. 1761 S. 1690 S. 1680 S. 1679 S. 1615 S. 1580 S. 1555 S. 1542 S. 1534 S. 1526 S. 1513 S. 1512 S. 1511 S. 1503 S. 1501 S. 1500 S. 1498 S. 1495 S. 1493 S. 1471 S. 1467 S. 1413 S. 1383 S. 1360 S. 1348 S. 1320 S. 1316 S. 1271 S. 1237 S. 1229 S. 1218 S. 1215 S. 1156 S. 1143 S. 1136 S. 1096 S. 1049 S. 986 S. 974 S. 965 S. 871 S. 858 S. 703 S. 675 S. 645 S. 622 S. 401 S. 373 S. 208 S. 191 S. 164 S. 114 S. 98 S. 30 S.J.Res. 10 S.Res. 160 S.Res. 72 S.Res. 24 S.Res. 11 S.Res. 42 H.R. 1553 H.R. 2565 H.R. 489 H.Res. 403 H.R. 3746 H.R. 2970 H.R. 2942 H.R. 2941 H.R. 2195 H.R. 2056 H.R. 1779 H.R. 1092 H.R. 955 H.R. 2326 H.J.Res. 46 H.R. 1293 H.R. 3611 H.R. 3038 H.R. 2495 H.R. 3306 H.R. 2795 H.R. 3458 H.R. 2945 H.R. 1891 H.R. 3161 H.Con.Res. 18 S.Con.Res. 3 H.R. 2406 H.R. 3802 H.R. 2342 H.R. 1090 H.R. 814 H.R. 2022 H.R. 2689 H.R. 1076 H.R. 1931 H.R. 112 H.R. 3420 H.R. 2098 H.R. 1078 H.R. 1893 H.R. 2483 H.R. 2226 H.R. 3524 H.R. 3508 H.R. 336 H.R. 1837 H.R. 3576 H.R. 3064 H.R. 2949 H.R. 2419 H.R. 2354 H.R. 1653 H.R. 910 H.Res. 442 H.Res. 309 H.Res. 302 H.Res. 214 H.R. 2166 H.R. 618 H.R. 2979 H.R. 3190 H.R. 1193 H.R. 1810 H.R. 2904 H.R. 442 H.R. 1332 H.R. 3652 H.R. 3840 H.R. 3801 H.R. 3727 H.R. 3724 H.R. 3658 H.R. 3588 H.R. 3567 H.R. 3505 H.R. 3467 H.R. 3400 H.R. 3313 H.R. 3309 H.R. 3266 H.R. 3247 H.R. 3227 H.R. 3226 H.R. 3216 H.R. 3191 H.R. 3186 H.R. 3185 H.R. 3181 H.R. 3177 H.R. 3176 H.R. 3175 H.R. 3174 H.R. 3173 H.R. 3166 H.R. 3148 H.R. 3143 H.R. 3137 H.R. 3132 H.R. 3093 H.R. 3087 H.R. 3084 H.R. 3065 H.R. 3046 H.R. 3045 H.R. 3041 H.R. 3034 H.R. 3015 H.R. 2954 H.R. 2953 H.R. 2952 H.R. 2944 H.R. 2937 H.R. 2907 H.R. 2892 H.R. 2880 H.R. 2869 H.R. 2814 H.R. 2811 H.R. 2794 H.R. 2767 H.R. 2762 H.R. 2759 H.R. 2756 H.R. 2598 H.R. 2555 H.R. 2554 H.R. 2450 H.R. 2432 H.R. 2395 H.R. 2330 H.R. 2255 H.R. 2254 H.R. 2253 H.R. 2252 H.R. 2249 H.R. 2171 H.R. 2091 H.R. 2033 H.R. 1863 H.R. 1801 H.R. 1792 H.R. 1746 H.R. 1714 H.R. 1638 H.R. 1462 H.R. 1403 H.R. 1258 H.R. 1086 H.R. 1032 H.R. 1019 H.R. 1017 H.R. 914 H.R. 859 H.R. 853 H.R. 700 H.R. 620 H.R. 613 H.R. 563 H.R. 553 H.R. 491 H.R. 463 H.R. 351 H.R. 344 H.R. 311 H.R. 248 H.R. 238 H.Con.Res. 49 H.Con.Res. 43 H.Res. 468 H.Res. 440 H.Res. 361 H.Res. 229 H.Res. 219 H.Res. 177 H.Res. 134 H.Res. 126 H.Res. 124 H.Res. 99 H.Res. 96 H.Res. 29 S. 252 H.R. 2500 H.R. 2257 H.R. 1567 H.R. 2016 H.R. 3626 H.R. 3233 H.R. 2727 H.R. 2707 H.R. 2280 H.R. 2060 H.R. 1795 H.R. 1249 H.R. 1231 H.R. 1004 H.R. 889 H.R. 2987 H.R. 2028 H.Res. 413 H.R. 2388 H.R. 3014 H.R. 3517 H.R. 3178 H.R. 3072 H.R. 2947 H.R. 2886 H.R. 2618 H.R. 2617 H.R. 1911 H.R. 663 H.R. 333 H.R. 303 H.Res. 455 H.Res. 269 H.Res. 39 H.R. 2384 H.R. 2401 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 3042 H.R. 1201 H.R. 1966 H.R. 1183 H.R. 3219 H.R. 2699 H.Res. 288 H.R. 2803 H.R. 3815 H.R. 3429 H.R. 3416 H.R. 2371 H.R. 2501 H.R. 3523 H.R. 1384
2019 · second_quarter · Health Issues
Health issues impacting patients with rare diseases. H.R.2279: Safe Step Act. Rare Disease Advancement, Research, and Education Act (Legislation not yet introduced). Advancing Access to Targeted Therapies Act (Legislation not yet introduced). H.Res.242: Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases. Pediatric subspecialty loan repayment reauthorization. H.R.2507: Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 776/S.1173: Emergency Medical Services for Children Program Reauthorization Act of 2019. H.R.1379/S.560: Ensuring Lasting Smiles Act. H.R.2862: VACCINES Act of 2019. Copay Accumulator Adjustment Programs (CAAPs). The Patient-Centered Outcomes Research Institute (PCORI) Reauthorization (Legislation not yet introduced). H.R.2501: Medical Nutrition Equity Act. H.R.1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. H.R.986: Protecting Americans with Preexisting Conditions Act of 2019. H.R.1884: Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019. S.1125: Protect Act. RIN 0938-ZB45: Patient Protection and Affordable Care Act; Increasing Consumer Choice Through the Sale of Individual Health Insurance Coverage Across State Lines Through Health Care Choice Compacts. H.R.1386/S.1905: ENROLL Act of 2019. H.R.2073/S.110: Medical Expense Savings Act. Guidance on Compliance with the Congressional Review Act.
Client expense: $90,000 · Firm income: Not reported
2019 · second_quarter · Health Issues
Promote federal funding for mitochondrial disease research, FY20 Defense Appropriations Act (Title V - Health); FY20 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Budget/Appropriations
Promote federal funding for mitochondrial disease research, FY20 Defense Appropriations Act (Title V - Health); FY20 Labor-HHS Appropriations (NIH); Medical nutrition legislation; H.R. 2501, Medical Nutrition Equity Act of 2019.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Referred to |
| May 2, 2019 |
| Democratic |
| NJ |
| Andy Levin | Democratic | MI |
| Ann M. Kuster | Democratic | NH |
| Ayanna Pressley | Democratic | MA |
| Barbara Lee | Democratic | CA |
| Ben McAdams | Democratic | UT |
| Bennie G. Thompson | Democratic | MS |
| Betty McCollum | Democratic | MN |
| Bobby L. Rush | Democratic | IL |
| Brian Higgins | Democratic | NY |
| Brian K. Fitzpatrick | Republican | PA |
| Carolyn B. Maloney | Democratic | NY |
| Chellie Pingree | Democratic | ME |
| Chris Stewart | Republican | UT |
| Colin Z. Allred | Democratic | TX |
| Conor Lamb | Democratic | PA |
| Darren Soto | Democratic | FL |
| David J. Trone | Democratic | MD |
| Dean Phillips | Democratic | MN |
| Debbie Dingell | Democratic | MI |
| Don Bacon | Republican | NE |
| Donald M. Payne, Jr. | Democratic | NJ |
| Earl Blumenauer | Democratic | OR |
| Ed Case | Democratic | HI |
| Ed Perlmutter | Democratic | CO |
| Eleanor Holmes Norton | Democratic | DC |
| G. K. Butterfield | Democratic | NC |
| Grace F. Napolitano | Democratic | CA |
| Grace Meng | Democratic | NY |
| Gwen Moore | Democratic | WI |
| Harley Rouda | Democratic | CA |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| Ilhan Omar | Democratic | MN |
| Jaime Herrera Beutler | Republican | WA |
| James A. Himes | Democratic | CT |
| Jamie Raskin | Democratic | MD |
| Jared F. Golden | Democratic | ME |
| Joe Neguse | Democratic | CO |
| John H. Rutherford | Republican | FL |
| John Lewis | Democratic | GA |
| John R. Moolenaar | Republican | MI |
| Joseph P. Kennedy III | Democratic | MA |
| Josh Gottheimer | Democratic | NJ |
| Joyce Beatty | Democratic | OH |
| Kendra S. Horn | Democratic | OK |
| Kim Schrier | Democratic | WA |
| Lauren Underwood | Democratic | IL |
| Lucille Roybal-Allard | Democratic | CA |
| Lucy McBath | Democratic | GA |
| Madeleine Dean | Democratic | PA |
| Mark DeSaulnier | Democratic | CA |
| Mark Pocan | Democratic | WI |
| Max Rose | Democratic | NY |
| Michael K. Simpson | Republican | ID |
| Mike Levin | Democratic | CA |
| Nanette Diaz Barragán | Democratic | CA |
| Peter Welch | Democratic | VT |
| Raja Krishnamoorthi | Democratic | IL |
| Rashida Tlaib | Democratic | MI |
| Rick Larsen | Democratic | WA |
| Ron Kind | Democratic | WI |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Scott R. Tipton | Republican | CO |
| Stephen F. Lynch | Democratic | MA |
| Steve Cohen | Democratic | TN |
| Susan W. Brooks | Republican | IN |
| Susan Wild | Democratic | PA |
| Suzan K. DelBene | Democratic | WA |
| TJ Cox | Democratic | CA |
| Terri A. Sewell | Democratic | AL |
| Theodore E. Deutch | Democratic | FL |
| Thomas R. Suozzi | Democratic | NY |
| Tim Ryan | Democratic | OH |
| Tom Cole | Republican | OK |
| Tom Malinowski | Democratic | NJ |
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), Natl Archives & Records Administration (NARA), Navy, Dept of, SENATE, U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), Natl Archives & Records Administration (NARA), Navy, Dept of, SENATE, U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), Natl Archives & Records Administration (NARA), Navy, Dept of, SENATE, U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), Natl Archives & Records Administration (NARA), Navy, Dept of, SENATE, U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), Natl Archives & Records Administration (NARA), Navy, Dept of, SENATE, U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE